Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Priming in Pediatric AML
NCT01177540Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of decitabine in acute myeloid leukemia (AML), sponsored by Eisai Co., Ltd.. Started Mar 2011; status: terminated.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01177540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01177540.